Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

MVAC regimen

View Patient Information
A regimen consisting of methotrexate, vinblastine, doxorubicin, and cisplatin used for the treatment of advanced-stage urothelial carcinoma, including bladder cancer.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:M-VAC regimen
methotrexate-vinblastine sulfate-doxorubicin hydrochloride-cisplatin regimen
methotrexate-vinblastine-adriamycin-cisplatin regimen
methotrexate-vinblastine-doxorubicin-cisplatin regimen
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search